drug protocol number

D169CC00001

drug sponsor

AstraZeneca

drug study

Dapagliflozin

drug trial site

King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz University Hospital (Jeddah), Saud Al-Babtain Cardiac Center (Dammam), King Abdulaziz Medical City NG (Riyadh), King Fahad Medical City (Riyadh)

drug status

Ongoing

drug phase